Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06124508

PromotinG Lung Cancer screenIng Awareness and Implementation in Hispanics/Latinx Head and Neck canceR Survivors

GUIAR: PromotinG Lung Cancer screenIng Awareness and Implementation in Hispanics/Latinx Head and Neck canceR Survivors

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
44 (estimated)
Sponsor
University of Miami · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to assess the awareness of eligibility of lung cancer screening in Hispanic/LatinX Head and Neck Cancer (HNC) survivors using a survey questionnaire; and to understand the barriers to screening using qualitative interviews.

Conditions

Interventions

TypeNameDescription
BEHAVIORALLung Cancer Screening EducationTailored lung cancer screening education will consist of an annual, in-person 60 minute visit of lung cancer screening education in the participant's native language with material in layman's terms about the importance of lung cancer screening, tobacco cessation, and the risk of developing a second primary lung cancer.
BEHAVIORALSemi-Structured InterviewParticipants will undergo an annual, in-person or virtual, semi-structured interviews to understand barriers and perception towards screening and cultural competencies to increase adherence to lung cancer screening. The interviews will last approximately 30 minutes at each visit.
BEHAVIORALStandard of Care Lung Cancer Screening ProgramParticipants will receive standard of care referral to the University of Miami's Lung Cancer Screening Program. The standard education includes a one-time, in-person or virtual 60-minute visit with the Advanced Practice Registered Nurse (APRN) to review educational material about lung cancer screening and tobacco cessation guidelines, and to discuss the risks versus benefits of undergoing screening.

Timeline

Start date
2024-04-11
Primary completion
2026-04-30
Completion
2026-04-30
First posted
2023-11-09
Last updated
2025-04-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06124508. Inclusion in this directory is not an endorsement.